[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.90.95. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
September 1987

Genetic Susceptibility to Toxic Epidermal Necrolysis

Author Affiliations

From the Service de Dermatologie and the Centre Départemental de Transfusion Sanguine, Hôpital Henri Mondor, Université Paris Val-de-Marne, 94010 Créteil, France.

Arch Dermatol. 1987;123(9):1171-1173. doi:10.1001/archderm.1987.01660330082014
Abstract

• The pathophysiologic events leading to toxic epidermal necrolysis (TEN) remain unknown. With the idea of an immunologically mediated reaction occurring in predisposed subjects we performed HLA-A, -B and -DR typing in 44 patients surviving TEN. We observed a significant increase of only HLA-B12, previously found associated with ocular complications of Stevens-Johnson syndrome. When patients were stratified according to the drugs involved as causes for their TEN, we found other HLA phenotypes associated with B12, varying with each category of drugs. Sulfonamide-related cases of TEN were linked to A29, B12, and DR7, while oxicam-related cases of TEN were linked to A2 and B12. These results suggest that a genetic background, related to the major histocompatibility complex, may contribute to severe blistering drug reactions.

(Arch Dermatol 1987;123:1171-1173)

×